DK3077512T3 - Immunogene sammensætninger og vacciner afledt fra bakterielle overfladereceptorproteiner - Google Patents
Immunogene sammensætninger og vacciner afledt fra bakterielle overfladereceptorproteiner Download PDFInfo
- Publication number
- DK3077512T3 DK3077512T3 DK14866832.0T DK14866832T DK3077512T3 DK 3077512 T3 DK3077512 T3 DK 3077512T3 DK 14866832 T DK14866832 T DK 14866832T DK 3077512 T3 DK3077512 T3 DK 3077512T3
- Authority
- DK
- Denmark
- Prior art keywords
- surface receptor
- immunogenic compositions
- receptor proteins
- bacterial surface
- vaccines derived
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
- A61K39/1045—Moraxella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361910817P | 2013-12-02 | 2013-12-02 | |
| US201462007068P | 2014-06-03 | 2014-06-03 | |
| PCT/CA2014/051146 WO2015081430A1 (en) | 2013-12-02 | 2014-12-01 | Immunogenic compositions and vaccines derived from bacterial surface receptor proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3077512T3 true DK3077512T3 (da) | 2022-05-16 |
Family
ID=53272682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14866832.0T DK3077512T3 (da) | 2013-12-02 | 2014-12-01 | Immunogene sammensætninger og vacciner afledt fra bakterielle overfladereceptorproteiner |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10149900B2 (da) |
| EP (2) | EP3077512B1 (da) |
| JP (1) | JP2016539950A (da) |
| KR (2) | KR20160110368A (da) |
| CN (2) | CN105980562B (da) |
| AU (1) | AU2014360590B2 (da) |
| BR (1) | BR112016012285A2 (da) |
| CA (1) | CA2931685C (da) |
| DK (1) | DK3077512T3 (da) |
| EA (1) | EA037909B1 (da) |
| ES (1) | ES2912751T3 (da) |
| NZ (1) | NZ721121A (da) |
| PL (1) | PL3077512T3 (da) |
| WO (1) | WO2015081430A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017136947A1 (en) * | 2016-02-10 | 2017-08-17 | Moraes Trevor F | Slam polynucleotides and polypeptides and uses thereof |
| WO2019074934A1 (en) * | 2017-10-09 | 2019-04-18 | Healthtell Inc. | IMMUNOGENS FOR DIRECTED IMMUNE RESPONSE AND ANTIBODIES THEREFROM |
| CN109239341B (zh) * | 2018-07-04 | 2021-08-24 | 西南大学 | 一种牛溶血性曼氏杆菌抗体检测的间接elisa试剂盒及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5268463A (en) | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
| US5292869A (en) | 1989-04-27 | 1994-03-08 | The Board Of Governors Of The University | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
| FR2682114B1 (fr) | 1991-10-03 | 1996-02-23 | Pasteur Merieux Serums Vacc | Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie. |
| US5417971A (en) | 1991-10-22 | 1995-05-23 | University Of Saskatchewan | Vaccines for Actinobacillus pleuropneumoniae |
| FR2692592B1 (fr) | 1992-06-19 | 1995-03-31 | Pasteur Merieux Serums Vacc | Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant. |
| US6361779B1 (en) | 1993-11-08 | 2002-03-26 | Aventis Pasteur Limited | Transferrin receptor genes |
| US6048539A (en) | 1995-11-02 | 2000-04-11 | Connaught Laboratories Limited | Lactoferrin receptor protein |
| BR9611851A (pt) * | 1995-12-01 | 1999-12-28 | Reggie Y C Lo | Molécula de ácido nucléico isolada e purificada, vetor de experessão recombinatória, célula hospedeira contendo um vetor de expressão recombina tório, proteìnas tbpa e tbpb isolada e purificadas, método para preparar uma protéina tbpa e tbpb, anti-corpo policlÈnico ou monoclÈnico, e vacinas assim obtidas |
| US6610506B1 (en) | 1995-12-01 | 2003-08-26 | University Technologies International, Inc. | Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same |
| FR2767060B1 (fr) * | 1997-08-07 | 2000-02-11 | Pasteur Merieux Serums Vacc | Vaccin meningocoque comportant la valence de souche bz83 |
| US6391316B1 (en) | 1999-03-10 | 2002-05-21 | University Of Saskatchewan | Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use |
| US7241449B1 (en) | 1999-04-12 | 2007-07-10 | Aventis Pasteur Limited | Transferrin receptor genes of moraxella |
| US20040258695A1 (en) | 2003-01-31 | 2004-12-23 | Schryvers Anthony Bernard | Transferrin binding peptides and uses thereof |
-
2014
- 2014-12-01 CN CN201480072859.1A patent/CN105980562B/zh active Active
- 2014-12-01 CN CN202510901559.XA patent/CN120771269A/zh active Pending
- 2014-12-01 CA CA2931685A patent/CA2931685C/en active Active
- 2014-12-01 KR KR1020167017381A patent/KR20160110368A/ko not_active Ceased
- 2014-12-01 BR BR112016012285A patent/BR112016012285A2/pt not_active Application Discontinuation
- 2014-12-01 AU AU2014360590A patent/AU2014360590B2/en active Active
- 2014-12-01 WO PCT/CA2014/051146 patent/WO2015081430A1/en not_active Ceased
- 2014-12-01 EP EP14866832.0A patent/EP3077512B1/en active Active
- 2014-12-01 PL PL14866832.0T patent/PL3077512T3/pl unknown
- 2014-12-01 US US15/100,867 patent/US10149900B2/en active Active
- 2014-12-01 EA EA201691140A patent/EA037909B1/ru unknown
- 2014-12-01 ES ES14866832T patent/ES2912751T3/es active Active
- 2014-12-01 NZ NZ721121A patent/NZ721121A/en unknown
- 2014-12-01 DK DK14866832.0T patent/DK3077512T3/da active
- 2014-12-01 JP JP2016535135A patent/JP2016539950A/ja active Pending
- 2014-12-01 KR KR1020207033592A patent/KR102507993B1/ko active Active
- 2014-12-01 EP EP22155082.5A patent/EP4074830A3/en active Pending
-
2018
- 2018-10-25 US US16/170,420 patent/US20190117756A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN105980562A (zh) | 2016-09-28 |
| NZ721121A (en) | 2020-09-25 |
| AU2014360590B2 (en) | 2019-05-16 |
| CA2931685A1 (en) | 2015-06-11 |
| US20190117756A1 (en) | 2019-04-25 |
| KR102507993B1 (ko) | 2023-03-15 |
| EP3077512A1 (en) | 2016-10-12 |
| CA2931685C (en) | 2021-09-07 |
| KR20160110368A (ko) | 2016-09-21 |
| EA037909B1 (ru) | 2021-06-04 |
| WO2015081430A1 (en) | 2015-06-11 |
| EP4074830A3 (en) | 2023-01-18 |
| EP3077512B1 (en) | 2022-02-09 |
| AU2014360590A1 (en) | 2016-07-14 |
| JP2016539950A (ja) | 2016-12-22 |
| US10149900B2 (en) | 2018-12-11 |
| BR112016012285A2 (pt) | 2017-09-26 |
| PL3077512T3 (pl) | 2022-07-18 |
| KR20200135563A (ko) | 2020-12-02 |
| CN120771269A (zh) | 2025-10-14 |
| EP3077512A4 (en) | 2017-09-06 |
| CN105980562B (zh) | 2025-07-18 |
| EP4074830A2 (en) | 2022-10-19 |
| ES2912751T3 (es) | 2022-05-27 |
| US20160303217A1 (en) | 2016-10-20 |
| EA201691140A1 (ru) | 2017-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279395A (en) | A vaccine | |
| DK3494985T3 (da) | Vaccinesammensætning omfattende mutant calreticulin | |
| DK3244917T3 (da) | Immunogene sammensætninger til anvendelse i pneumokokvacciner | |
| DK3570879T3 (da) | Immunogene sammensætninger til anvendelse i pneumokokvacciner | |
| DK3421051T3 (da) | Fremgangsmåder til glycokonjugering og sammensætninger | |
| HUE055044T2 (hu) | MRNS-kódolt ellenanyagok bejuttatására szolgáló eljárások és készítmények | |
| DK3008168T3 (da) | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf | |
| HUE054847T2 (hu) | Rekombináns Zika-vakcinák | |
| DK3207053T3 (da) | Hidtil ukendte immunogene peptider | |
| DK3170508T3 (da) | Vaccineformuleringer | |
| DK3321287T3 (da) | Fusionsproteiner og kombinationsvacciner | |
| IL238499B (en) | A multivalent disulfide-linked type I Mhc containing multi-functional proteins | |
| ZA201604498B (en) | Single vial vaccine formulations | |
| LT3240895T (lt) | Kompozicijos ir būdai, skirti baltymų glikozilinimui | |
| DK3102189T3 (da) | Sammensætning og fremgangsmåde til at fremme søvn | |
| EP3655029C0 (en) | IMMUNOGENE COMPOSITION | |
| DK3220750T3 (da) | Oral rehydreringssammensætning og fremgangsmåder dertil | |
| DK2745849T3 (da) | Polydeoxyribonukleotidsammensætning og anvendelser deraf | |
| BR112013030395A2 (pt) | polipeptídeo, polinucleotídeo, vetor, composição imunogênica, vacina, e, uso de uma composição imunogênica | |
| HUE053033T2 (hu) | Hidrolázoknak ellenálló kapszidokat alkalmazó készítmények és eljárások | |
| DK3024428T3 (da) | Sammensætninger og fremgangsmåder til dental mineralisering | |
| DK3129007T3 (da) | Vaccinesammensætninger | |
| DK3608334T3 (da) | Tatk-cdkl5-fusionsproteiner, sammensætninger, formuleringer og anvendelse deraf | |
| DK2968479T3 (da) | Terapeutiske sure ceramidasesammensætninger og fremgangsmåder til fremstilling og anvendelse heraf | |
| EP2742058C0 (en) | ANTI-IL-6 VACCINE COMPOSITION |